Sector Expert: William Gregozeski

Mont Blanc Capital Management

Image: William Gregozeski

William Gregozeski has spent more than 10 years working as an industry-agnostic equity analyst covering securities listed around the world. Gregozeski currently manages the sellside equity research department and oversees U.S. client relationships at Mont Blanc Capital Management, a Zurich-based investment firm. Previous work includes writing sellside research on U.S.-listed small-cap companies at Gar Wood Securities, a Chicago-based broker dealer, and researching the cleantech industry in the U.S. and small-cap China-based companies at Capstone Investments, a San Diego-based broker dealer. Gregozeski is a CFA charterholder, has obtained a bachelor's degree in finance and a master's degree in business administration from Marquette University, and currently holds FINRA Series 7, 24, 66, 79, 86, and 87 licenses.



Recent Quotes

"BTI's Transcend platform is a huge financial incentive to the owner of the therapy because it could greatly extend the drug's exclusivity."

The Life Sciences Report Interview with William Gregozeski (5/16/13)
more >

"BTI's BT2111 shows significant advantages over Herceptin."

— William Gregozeski, Mont Blanc Capital Management (2/11/13)
more >



Due to permission requirements, not all quotes are shown.